Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-22

Clinical Trial Update: Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ribavirin pre-treatment followed by a combined standard therapy regimen in hepatitis C virus patients has completed. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED